IPOs/recent issues: Orchid Biosciences –

Princeton, N.J.

Went public 5/5/2000 at $8 apiece

Filing Range: 6 mil. shares @ $8 to $9

Outstanding Shares: 31.98 mil. shares

Underwriters: Credit Suisse First Boston

FleetBoston Corp./Salomon Smith Barney

Company Counsel:Mintz Levin Cohn Ferris & Glovsky

Manager Counsel: Willkie Farr & Gallagher

Auditor:KPMG LLP

The Company:

Develops computer micro-engineering technology for drug design. Develops microfluidic systems to revolutionize chemical synthesis and biological analysis for drug discovery and diagnostics.

Venture Backers:

Taiwan Venture Capital Corp.

Affymetrix Inc.

Oxford Bioscience Partners

Weiss, Peck & Greer Venture Partners LP

Motorola Inc.

Burrill & Co.

Financing Rounds

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 12/19/1997 6 Expansion $5995.0

2 01/01/1998 1 Expansion 1000.0

3 04/01/1998 7 Expansion 27500.2

4 12/01/1999 5 Expansion 72000.0

FINANCIALS

Data in $ millions)

Y/E

12/31/99

Total Revenues: $1.8

Net Loss: -20.1